BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 25356906)

  • 1. The effect of radiation quality on the risks of second malignancies.
    Manem VS; Kohandel M; Hodgson DC; Sharpe MB; Sivaloganathan S
    Int J Radiat Biol; 2015 Mar; 91(3):209-17. PubMed ID: 25356906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiobiology with heavy charged particles: a historical review.
    Skarsgard LD
    Phys Med; 1998 Jul; 14 Suppl 1():1-19. PubMed ID: 11542635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk assessment for cancer induction after low- and high-LET therapeutic irradiation.
    Engels H; Menzel HG; Pihet P; Wambersie A
    Strahlenther Onkol; 1999 Jun; 175 Suppl 2():47-51. PubMed ID: 10394397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative treatment planning using secondary cancer mortality calculations.
    Schneider U; Lomax A; Lombriser N
    Phys Med; 2001; 17 Suppl 1():97-9. PubMed ID: 11770547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations induced by heavy charged particles.
    Yatagai F
    Biol Sci Space; 2004 Dec; 18(4):224-34. PubMed ID: 15858389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical physics aspects of particle therapy.
    Jäkel O
    Radiat Prot Dosimetry; 2009 Nov; 137(1-2):156-66. PubMed ID: 19828718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monte Carlo mixture model of lifetime cancer incidence risk from radiation exposure on shuttle and international space station.
    Peterson LE; Cucinotta FA
    Mutat Res; 1999 Dec; 430(2):327-35. PubMed ID: 10631348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproton radiotherapy.
    Bassler N; Alsner J; Beyer G; DeMarco JJ; Doser M; Hajdukovic D; Hartley O; Iwamoto KS; Jäkel O; Knudsen HV; Kovacevic S; Møller SP; Overgaard J; Petersen JB; Solberg TD; Sørensen BS; Vranjes S; Wouters BG; Holzscheiter MH
    Radiother Oncol; 2008 Jan; 86(1):14-9. PubMed ID: 18158194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High relative biologic effectiveness of carbon ion radiation on induction of rat mammary carcinoma and its lack of H-ras and Tp53 mutations.
    Imaoka T; Nishimura M; Kakinuma S; Hatano Y; Ohmachi Y; Yoshinaga S; Kawano A; Maekawa A; Shimada Y
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):194-203. PubMed ID: 17707273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of relative biological effectiveness dependence on linear energy transfer for low-LET radiations.
    Hunter N; Muirhead CR
    J Radiol Prot; 2009 Mar; 29(1):5-21. PubMed ID: 19225189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calculated LET spectrum from antiproton beams stopping in water.
    Bassler N; Holzscheiter M
    Acta Oncol; 2009; 48(2):223-6. PubMed ID: 18932095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relevance of very low energy ions for heavy-ion therapy.
    Elsässer T; Gemmel A; Scholz M; Schardt D; Krämer M
    Phys Med Biol; 2009 Apr; 54(7):N101-6. PubMed ID: 19287080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of radiation tolerance to high LET heavy ions in an anhydrobiotic insect, Polypedilum vanderplanki.
    Watanabe M; Sakashita T; Fujita A; Kikawada T; Nakahara Y; Hamada N; Horikawa DD; Wada S; Funayama T; Kobayashi Y; Okuda T
    Int J Radiat Biol; 2006 Dec; 82(12):835-42. PubMed ID: 17178623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The LET spectra at different penetration depths along secondary 9C and 11C beams.
    Li Q; Komori M; Kanai T; Kitagawa A; Urakabe E; Kanazawa M; Tomitani T; Sato S
    Phys Med Biol; 2004 Nov; 49(22):5119-33. PubMed ID: 15609562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological effectiveness of (12)C and (20)Ne ions with very high LET.
    Czub J; Banaś D; Błaszczyk A; Braziewicz J; Buraczewska I; Choinski J; Gorak U; Jaskoła M; Korman A; Lankoff A; Lisowska H; Lukaszek A; Szeflinski Z; Wojcik A
    Int J Radiat Biol; 2008 Oct; 84(10):821-9. PubMed ID: 18979317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energy dependence of dose and dose-rate effectiveness factor for low-let radiations: potential importance to estimation of cancer risks and relationship to biological effectiveness.
    Trabalka JR; Kocher DC
    Health Phys; 2007 Jul; 93(1):17-27. PubMed ID: 17563489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does fractionation decrease the risk of breast cancer induced by low-LET radiation?
    Brenner DJ
    Radiat Res; 1999 Feb; 151(2):225-9. PubMed ID: 9952308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Charged particle cytogenetics: effects of LET, fluence, and particle separation on chromosome aberrations.
    Geard CR
    Radiat Res Suppl; 1985; 8():S112-21. PubMed ID: 3003782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.